Ebrahimi C, Musial MPM, Doñamayor N, Prychynenko DS, Bode EL, Spanagel R, Heinz A, Deserno L, Smolka MN, Ebner-Priemer U, Kliegl R, Endrass T, Reichert M, Rapp M, Schlagenhauf F. Goal-directed behavior and hippocampal activity predict real-life impact of drinking intentions in alcohol use disorder. Transl Psychiatry. 2025 15(1):425.
Friske MM, Torrico EC, Haas MJW, Borruto AM, Giannone F, Hade AC, Yu Y, Gao L, Sutherland GT, Hitzemann R, Philips MA, Fei SS, Sommer WH, Mayfield RD, Spanagel R. A systematic review and meta-analysis on the transcriptomic signatures in alcohol use disorder. Mol Psychiatry. 2025 30(1):310-326. Epub 2024 Sep 6.
Hartnagel LM, Ebner-Priemer U, Foo JC, Streit F, Witt SH, Frank J, Limberger MF, Horn AB, Gilles M, Rietschel M, Sirignano L. Linguistic style as a digital marker for depression severity: An ambulatory assessment pilot study in patients with depressive disorder undergoing sleep deprivation therapy. Acta Psychiatr Scand. 2025 151(3):348-357. Epub 2024 Jul 10.
Meinhardt M, Skorodumov I, Jeanblanc J, Benvenuti F, Hilal FF, Domi E, André C, Bodeau S, Jeanblanc V, Domanegg K, Ciccocioppo R, Naassila M, Spanagel R. A new module in the drug development process: preclinical multi-center randomized controlled trial of R-ketamine on alcohol relapse. Neuropsychopharmacology. 2025 50(6):886-894. Epub 2025 Feb 28.
Zillich L, Artioli A, Pohorala V, Zillich E, Stertz L, Belschner H, Jabali A, Frank J, Streit F, Avetyan D, Völker MP, Müller S, Hansson AC, Meyer TD, Rietschel M, Ladewig J, Spanagel R, Oliveira AMM, Walss-Bass C, Bernardi R, Koch P, Witt SH. Cell type-specific multi-omics analysis of cocaine use disorder in the human caudate nucleus. Nat Commun. 2025 16(1):3381.